Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Clinical trial NCT01044654 · COMPLETED
Trial details
- NCT number
- NCT01044654
- Sponsor
- Sangamo Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2014-12-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.